NeuraCap

Legal

Terms of Use

Last updated 20 September 2026

These terms govern your use of the NeuraCap platform, the research we publish and the reports you generate. They are written to be read. Where a clause limits what you can do, it says so directly rather than burying it.

In short

  • You may use NeuraCap for your own business and to advise your own clients, for as long as your subscription runs.
  • You may download a report and give it to your board, your lender, your advisers or your client. You may not resell it, republish it as your own product, or strip our name off it.
  • The analysis is information, not advice. Nothing in the product is a recommendation to buy or sell anything — see the disclaimer.
  • Fees are agreed in writing before you are charged. We do not publish a price list; see pricing.
  • New York law governs these terms, and our liability is capped at what you have paid us in the preceding twelve months.

1. Acceptance of these terms

By creating an account, signing in, using the platform, or downloading a report from this site, you agree to these terms. If you are agreeing on behalf of a company, firm or other organisation, you confirm that you have the authority to bind it, and “you” in these terms means that organisation.

If you do not agree, do not use the platform. You are still welcome to read the free industry research in the reports library, which is subject to section 7 and to the disclaimer.

Where you have signed a separate order form, subscription agreement or advisory engagement letter with NeuraCap, that document governs if it conflicts with these terms.

2. Eligibility and your account

NeuraCap is a business tool. You must be at least eighteen and using the platform for business purposes. You agree to give us accurate registration details and to keep them current.

Accounts are personal to the named individual. Keep your credentials secure, do not share a login, and tell us at once if you believe your account has been used without your permission. You are responsible for everything done through your account, and for the conduct of any colleague to whom you give access under your subscription.

3. Your licence to use the platform

For as long as your subscription is current and you are not in breach of these terms, we grant you a limited, non-exclusive, non-transferable, non-sublicensable and revocable licence to access and use the platform and the analysis it produces for your internal business purposes and for advising your own clients.

That covers the product as described on the platform overview: company search and analysis, private company evaluation, public comparables and KPI benchmarking, valuation analysis and the football-field chart, M&A precedent transactions, sector intelligence, the Financial Assistant, the Research Hub, and export to PDF and PPTX.

The licence does not transfer ownership of anything. We reserve all rights not expressly granted here.

4. Acceptable use

You agree not to:

  • Scrape, crawl, bulk-download or systematically extract data from the platform, by any means, whether or not automated.
  • Use the platform or its output to build, train or improve a competing dataset, model, product or service.
  • Resell, sublicense, rent or otherwise make the platform available to anyone who is not a permitted user under your subscription.
  • Reverse engineer, decompile or attempt to derive the source code, models or methodology of the platform, except to the extent that restriction is unenforceable by law.
  • Circumvent rate limits, access controls, entitlement checks or any other technical protection.
  • Submit information you are not entitled to disclose, including confidential information belonging to a third party, or personal information collected without a lawful basis.
  • Present platform output as independently audited, independently verified, or as an appraisal or fairness opinion. It is none of those things.
  • Use the platform unlawfully, including for market manipulation or insider dealing.
  • Interfere with the operation or security of the platform, or with any other customer’s use of it.

5. Using the analysis with your own clients

Advisers are a large part of who NeuraCap is built for, and the licence is meant to work for that. You may use the conclusions, figures, charts and commentary produced for you in your own client materials — pitch books, information memoranda, board papers, credit submissions and valuation discussions — provided you:

  • Attribute the analysis to NeuraCap where it is presented as a source.
  • Do not represent it as your own independent verification of the underlying data, or as work you performed.
  • Pass on the substance of our disclaimer when you share it, so your client understands what the numbers are and are not.
  • Do not give your client standing access to the platform under your subscription. If they want access, they need their own.

You remain responsible for the advice you give. If you need work that carries a person’s name and judgement behind it, that is an advisory engagement under a separate letter.

6. Intellectual property

NeuraCap and its licensors own the platform: the interface, the software, the methodology, the models, the benchmark and peer-set construction, the compilation and presentation of data, the report templates and the NeuraCap name and marks. The analysis we generate for you is licensed to you under section 3 and section 7, not assigned to you.

Underlying third-party data — filings data, consensus estimates, market prices and the transaction record described on our coverage and data page — remains the property of its providers and is used under licence. Your own trade marks and materials remain yours.

If you send us feedback or suggestions, you grant us a perpetual, royalty-free licence to use them to improve the product. We will not identify you as the source without your permission.

7. Report use and sharing rights

Reports generated for you

For any company report generated under your subscription or an advisory engagement, you may:

  • View it in the platform, print it, and export it to PDF or PPTX.
  • Store it on your own systems for your records.
  • Share the complete report with your board and management, with your lenders, with your professional advisers, with a counterparty in a transaction you are running, and with the client you prepared it for.

You may not:

  • Remove or obscure NeuraCap branding, the as-at date or the disclaimers.
  • Edit the report and continue to present it as a NeuraCap report.
  • Sell it, license it, or distribute it as a product of your own.
  • Publish it openly on a website, in a public filing or to the press without our prior written consent.

Free industry research

The industry research published in the reports library is free to read, free to download and ungated. You may quote from it and share it, including with clients, provided you attribute it to NeuraCap and link back to the report page. You may not repackage it for sale or present it as your own research. The full company report format is a platform and advisory deliverable and is not covered by that permission.

8. Your content and your data

You keep ownership of everything you submit — financial statements, operating figures, documents and the questions you ask. You grant us a licence to host, process and analyse it for the purpose of providing the service to you, and for no other purpose.

You confirm you have the right to submit what you submit, and that doing so does not breach a confidentiality obligation or a data protection law. How we store and protect it, how long we keep it and how to have it deleted are covered in our Privacy Policy, and the controls behind it are described on our security page.

9. Subscription, payment and renewal

Fees, billing frequency, subscription term and the number of permitted users are set out in your order form or engagement letter, agreed in writing before you are charged. We do not publish a price list; pricing is scoped to the work, and you can ask for a quote from the pricing page.

Fees are exclusive of taxes, which you pay in addition where they apply. Invoices are payable on the terms stated in your order form. If payment is overdue we may charge interest at the rate permitted by law and suspend access after giving you notice.

Unless your order form says otherwise, subscriptions renew for successive terms of the same length. Either party may stop a renewal by giving written notice before the renewal date. Fees for a renewal term may change, and we will tell you before the renewal takes effect. Fees already paid are not refundable for a partial period unless the law requires it or we have failed to provide the service.

10. Suspension and termination

You may close your account at any time. We may suspend or terminate your access if you materially breach these terms, if payment is overdue after notice, if your use creates a security or legal risk, or if we are required to by law. Where it is practical and lawful to do so, we will warn you first and give you a chance to fix the problem.

On termination, your licence under section 3 ends and access stops. For thirty days afterwards you may ask us to export the reports generated for you. Reports you already downloaded may be kept and used under section 7. Sections 6, 8, 12, 13, 14, 16 and 17 survive termination.

11. No investment advice, no fiduciary relationship

Nothing on the platform or this site is a recommendation to buy or sell any security, bond, treasury or other instrument, and nothing here is an offer or a solicitation of an offer. Valuations and multiples are estimates derived from third-party data; they are not appraisals and not fairness opinions. Using NeuraCap does not create a fiduciary, advisory, broker-dealer or investment-adviser relationship between us.

The full position is set out in the disclaimer, which forms part of these terms. How figures are sourced, verified and calculated is described in our methodology.

12. Disclaimer of warranties

The platform and everything it produces are provided “as is” and “as available”. To the fullest extent permitted by law, we disclaim all warranties, express or implied, including merchantability, fitness for a particular purpose, title and non-infringement.

We do not warrant that the platform will be uninterrupted or error-free, that defects will be corrected, or that the data or analysis is accurate, complete or current. We confirm figures against two independent sources and apply plausibility gates to exclude implausible multiples, as described in our methodology. Those are controls on quality. They are not a guarantee of accuracy, and you should not treat them as one.

13. Limitation of liability

To the fullest extent permitted by law, neither party is liable for indirect, incidental, special, consequential or punitive damages, or for lost profits, lost revenue, lost opportunity, trading or investment losses, loss of goodwill, or the cost of substitute services, however caused and on any theory of liability.

Our total aggregate liability arising out of or relating to these terms or the platform is limited to the amount you paid us in the twelve months immediately before the event giving rise to the claim.

Nothing in these terms excludes or limits liability that cannot lawfully be excluded or limited, including liability for fraud or fraudulent misrepresentation.

14. Indemnity

You will indemnify and hold NeuraCap harmless from claims, losses, liabilities and reasonable legal costs arising from your use of the platform in breach of these terms, from the information you submit, and from the way you redistribute or rely on the analysis in your own client work. We will tell you promptly about any claim, let you control the defence of it, and give you reasonable co-operation.

15. Changes to the service and these terms

We develop the platform continuously and may add, change or withdraw features. We will not make a change that materially reduces the core functionality you are paying for during a paid term without telling you first.

We may update these terms. The date at the top of the page shows the current version. If a change is material, we will give notice by email or inside the platform before it takes effect. Continuing to use NeuraCap after that means you accept the updated terms. If you do not accept them, stop using the platform and tell us.

16. Governing law and disputes

These terms and any dispute arising out of them are governed by the laws of the State of New York, United States of America, without regard to its conflict of laws rules. The United Nations Convention on Contracts for the International Sale of Goods does not apply.

Before starting proceedings, each party agrees to raise the dispute in writing and to spend thirty days trying to resolve it in good faith. If that fails, the state and federal courts located in New York County, New York have exclusive jurisdiction, and both parties consent to that venue. Where a mandatory consumer or local law gives you the right to bring a claim in your home jurisdiction, this clause does not take that right away.

17. General provisions

  • Entire agreement. These terms, the Privacy Policy, the disclaimer and any order form or engagement letter are the whole agreement between us on this subject.
  • Severability. If a clause is unenforceable, it is limited or removed to the minimum extent necessary and the rest stays in force.
  • No waiver. Not enforcing a right on one occasion does not waive it.
  • Assignment. You may not assign these terms without our written consent. We may assign them to an affiliate or to a successor in a merger or sale of the business.
  • Force majeure. Neither party is liable for delay or failure caused by events beyond its reasonable control.
  • Notices. We give notice by email to the address on your account or by a notice in the platform. You give notice to us at the address in section 18.
  • Relationship. Nothing here creates a partnership, joint venture, agency or employment relationship.

18. Contact

Questions about these terms, about what you may share with a client, or about a subscription should go to info@neuracap.ai. Put “Terms” in the subject line and we will get it to the right person.

For how we handle your data, read the Privacy Policy. For what the analysis does and does not claim, read the disclaimer. For how the figures are produced, read the methodology.

This document is a draft. It is subject to review and approval by counsel before launch, and the licence scope, liability cap and governing-law provisions above may change as a result.